The independent prediction of short-term relapse but not of disease-related death has also been shown for other candidate biomarkers in colorectal adenocarcinoma, including kallikrein-related peptidase 4 (KLK4) mRNA and miR-24-3p expression [38,39]. Here, KLK4 is linked to colorectal adenocarcinoma.